Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

GATA2 Expression Level in Chronic Myeloid Leukemia (CML) Patients Correlates with Their Prognostic Scores and Is Associated with Disease Stage at Diagnosis

Philippe Guardiola, MD, Corentin Orvain, Nick C.P. Cross, PhD, Martine Gardembas, MD, Marc Spentchian, MD, Estelle Pedrono, PhD, Diane Lambert, PhD, Anne Coutolleau, Anne Bouvier, MD, Odile Blanchet, MDPhD, Nicole Piard, MD, Norbert Ifrah, MD PhD, Frank Giles, MD MB, FRCPI, FRCPath, Andreas Hochhaus, MD, Jerald P. Radich, MD, Philippe Rousselot, MD PhD

Blood (2015) 126 (23): 2768.

https://doi.org/10.1182/blood.V126.23.2768.2768

Published: 2015

Journal Articles

Mutations In XPO1, POT1, BIRC3 and FBXW7 collectively Predict Poor Outcome At Diagnosis In CLL and MBL Independent From The SF3B1 and NOTCH1 Status

Nils Winkelmann, MD, Mathew J Rose-Zerilli, PhD, Jade Forster, Mathew Parry, PhD, Anton Parker, BSc, Anne Gardiner, Zadie Davies, BSC, Andrew J Steele, PhD, Helen Parker, PhD, Andrew Collins, PhD, Nick C.P. Cross, PhD, David Oscier, MD, Jonathan C Strefford

Blood (2013) 122 (21): 4138.

https://doi.org/10.1182/blood.V122.21.4138.4138

Published: 2013

Journal Articles

High Throughput Targeted Gene Sequencing in 738 Myelodysplastic Syndromes Patients Reveals Novel Oncogenic Genes, Rare Driver Mutations and Complex Molecular Signatures with Potential Impact for Patient Diagnosis and Prognosis in the Clinic

Elli Papaemmanuil, PhD, Moritz Gerstung, PhD, Luca Malcovati, MD, Sudhir Tauro, PhD, Gunes Gundem, PhD, Peter Van Loo, PhD, Andrea Pellagatti, PhD, Michael J Groves, PhD, Nick C.P. Cross, PhD, Carlo Gambacorti-Passerini, MD, Anthony R Green, MD, Jacqueline Boultwood, PhD, Paresh Vyas, MD, Eva Hellstrom-Lindberg, MD, David Bowen, MD, Mario Cazzola, MD, Michael R Stratton, MD, PhD, Peter Campbell, MD Phd

Blood (2012) 120 (21): LBA-5.

https://doi.org/10.1182/blood.V120.21.LBA-5.LBA-5

Published: 2012

Journal Articles

Prognostic Impact of Mutations in a Large Series of Patients with Myelofibrosis

Blood (2012) 120 (21): 431.

https://doi.org/10.1182/blood.V120.21.431.431

Published: 2012

Journal Articles

Whole-Exome Sequencing of 8 Atypical Chronic Myeloid Leukaemia Patients,

Rocco Piazza, MD, PhD, Simona Valletta, M.Sc., Alessandra Pirola, M.Sc., Hima Raman, M.Sc., Roberta Spinelli, M.Sc., Nick C.P. Cross, PhD, Caterina Cecchetti, MD, Zaira Sortino, B.Sc., Carlo Gambacorti-Passerini, MD

Blood (2011) 118 (21): 3853.

https://doi.org/10.1182/blood.V118.21.3853.3853

Published: 2011

Journal Articles

Novel PDGFRA Point Mutations in Hypereosinophilic Syndrome Induce Growth Factor Independence and Leukemia in Vitro and In Vivo.

Christian Elling, Philipp Erben, MD, Christoph Walz, MD, Marie Frickenhaus, Mirle Schemionek, PhD, Martin Stehling, PhD, Hubert Serve, MD, PhD, Nick C.P. Cross, PhD, Wolfgang Berdel, MD, Carsten Mueller-Tidow, MD, Andreas Reiter, MD, Steffen Koschmieder, MD

Blood (2009) 114 (22): 767.

https://doi.org/10.1182/blood.V114.22.767.767

Published: 2009

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

GATA2 Expression Level in Chronic Myeloid Leukemia (CML) Patients Correlates with Their Prognostic Scores and Is Associated with Disease Stage at Diagnosis

Mutations In XPO1, POT1, BIRC3 and FBXW7 collectively Predict Poor Outcome At Diagnosis In CLL and MBL Independent From The SF3B1 and NOTCH1 Status

High Throughput Targeted Gene Sequencing in 738 Myelodysplastic Syndromes Patients Reveals Novel Oncogenic Genes, Rare Driver Mutations and Complex Molecular Signatures with Potential Impact for Patient Diagnosis and Prognosis in the Clinic

Prognostic Impact of Mutations in a Large Series of Patients with Myelofibrosis

Whole-Exome Sequencing of 8 Atypical Chronic Myeloid Leukaemia Patients,

Novel PDGFRA Point Mutations in Hypereosinophilic Syndrome Induce Growth Factor Independence and Leukemia in Vitro and In Vivo.

Email alerts

ASH Publications

American Society of Hematology

Update search

GATA2 Expression Level in Chronic Myeloid Leukemia (CML) Patients Correlates with Their Prognostic Scores and Is Associated with Disease Stage at Diagnosis

Mutations In XPO1, POT1, BIRC3 and FBXW7 collectively Predict Poor Outcome At Diagnosis In CLL and MBL Independent From The SF3B1 and NOTCH1 Status

High Throughput Targeted Gene Sequencing in 738 Myelodysplastic Syndromes Patients Reveals Novel Oncogenic Genes, Rare Driver Mutations and Complex Molecular Signatures with Potential Impact for Patient Diagnosis and Prognosis in the Clinic

Prognostic Impact of Mutations in a Large Series of Patients with Myelofibrosis

Whole-Exome Sequencing of 8 Atypical Chronic Myeloid Leukaemia Patients,

Novel PDGFRA Point Mutations in Hypereosinophilic Syndrome Induce Growth Factor Independence and Leukemia in Vitro and In Vivo.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only